[Long-term medicinal prevention in patients who have suffered myocardial infarction].
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005081:Exercise Therapy; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007501:Iron / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control*; D012008:Recurrence; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D000959:Antihypertensive Agents; D006993:Hypnotics and Sedatives; D004176:Dipyridamole; D007501:Iron; D002994:Clofibrate
Dulgosrochna medikamentozna profilaktika pri bolni, prekarali surdechen infarkt